One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Guideline Development and Implementation in Rheumatic Disease
MICHAEL M. WARD
doi : 10.1016/S0889-857X(22)00056-4
Volume 48, Issue 3, August 2022, Page i
Guideline Development and Implementation in Rheumatic Disease
Michael H. Weisman, MD
doi : 10.1016/j.rdc.2022.06.013
Volume 48, Issue 3, August 2022, Pages xiii-xiv
A Guide to Contemporary Clinical Practice Guidelines
Michael M. Ward, MD, MPH
doi : 10.1016/j.rdc.2022.06.012
Volume 48, Issue 3, August 2022, Pages xv-xvi
How the American College of Rheumatology Develops Guidelines
Sindhu R. Johnson, MD, PhD a, *, Amy S. Turner b , Susan M. Goodman, MD
doi : 10.1016/j.rdc.2022.04.001
Volume 48, Issue 3, August 2022, Pages 579-588
The GRADE Method
Aydia Mayan Caplan a,b , Liron Caplan, MD, PhD a,b,
doi : 10.1016/j.rdc.2022.04.002
Volume 48, Issue 3, August 2022, Pages 589-599
Taxonomy of Quality of Care Indicators: Tracing the Path from Clinical Practice Guidelines to Quality Measurement and Beyond
Elizabeth Wahl, MD, MAS a,b , Una E. Makris, MD, MSc c , Lisa G. Suter, MD
doi : 10.1016/j.rdc.2022.03.004
Volume 48, Issue 3, August 2022, Pages 601-615
Recommendations for Systemic Lupus Erythematosus: Balancing Evidence and Eminence to Facilitate the Medical Care of a Complex Disease
George Bertsias,
doi : 10.1016/j.rdc.2022.05.001
Volume 48, Issue 3, August 2022, Pages 617-636
Osteoarthritis Treatment Guidelines from Six Professional Societies: Similarities and Differences
Chris Overton, MD a , Amanda E. Nelson, MD, MSCR a , Tuhina Neogi, MD, PhD
doi : 10.1016/j.rdc.2022.03.009
Volume 48, Issue 3, August 2022, Pages 637-657
Treatment Guidelines in Gout
Allan C. Gelber,
doi : 10.1016/j.rdc.2022.04.003
Volume 48, Issue 3, August 2022, Pages 659-678
Treatment Guidelines in Rheumatoid Arthritis
Jasvinder A. Singh, MBBS, MPH
doi : 10.1016/j.rdc.2022.03.005
Volume 48, Issue 3, August 2022, Pages 679-689
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development
Jamal Mikdashi,
doi : 10.1016/j.rdc.2022.05.002
Volume 48, Issue 3, August 2022, Pages 691-703
Treatment Guidelines in Vasculitis
Tanaz A. Kermani, MD, MS a , Kenneth J. Warrington, MD b , Anisha B. Dua, MD, MPH
doi : 10.1016/j.rdc.2022.03.006
Volume 48, Issue 3, August 2022, Pages 705-724
Treatment Guidelines in Pediatric Rheumatic Diseases
Ekemini A. Ogbu, MD, MSc a,b, *, Hermine I. Brunner, MD, MBA
doi : 10.1016/j.rdc.2022.03.007
Volume 48, Issue 3, August 2022, Pages 725-746
The Evaluation of Guideline Quality in Rheumatic Diseases
Claire E.H. Barber, MD, PhD, FRCPC a,b,c, *, Cheryl Barnabe, MD, MSc, FRCPC a,b,c , Nicole M.S. Hartfeld, MSc, MC, CCC b , Kiran Dhiman, MPH b , Glen S. Hazlewood, MD, PhD, FRCPC
doi : 10.1016/j.rdc.2022.03.008
Volume 48, Issue 3, August 2022, Pages 747-761
